GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis (PLoS ONE)
Saxenda (active ingredient: liraglutide) subcutaneous injection Initial FDA Approval: 2014 (liraglutide approved in 2010) Side Effect Update Date: May 28, 2025 Medication Description: For chronic weight management Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
The following history attempts to correct the traditional narrative by capturing some of the women's voices and the many different roles they played alongside male colleagues in shaping the development of GLP-1 drugs
Recent data from the military suggest that about five percent of all the mild TBI cases suffer from postconcussion syndrome, which still represents a high number of cases (Ling, 2010)
On days you dont train, take any time during the day
Obesity Is About More Than Weight Obesity is associated with type 2 diabetes, high blood pressure, heart disease, sleep apnea, and more
